Loading…
Evaluation of serum interleukin-33 and gene polymorphisms in patients with bronchial asthma
Aims: Asthma is a chronic inflammatory disease of the airways. The aim of the study was to investigate the association between serum interleukin (IL)-33 level and IL-33 gene rs1342326, rs1929992 and rs3939286 polymorphisms in patients with asthma. Methods: Ninety patients aged 18 years and older, wh...
Saved in:
Published in: | Gulhane Medical Journal 2021-06, Vol.63 (2), p.104-109 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 109 |
container_issue | 2 |
container_start_page | 104 |
container_title | Gulhane Medical Journal |
container_volume | 63 |
creator | Canoglu, Kadir Okutan, Oguzhan Tas, Dilaver Yilmaz, Ismail Yesilbas, Soner Caliskan, Tayfun Kosar, Ayse Filiz Arpacag Kartaloglu, Zafer Ayten, Omer Uyar, Yasin |
description | Aims: Asthma is a chronic inflammatory disease of the airways. The aim of the study was to investigate the association between serum interleukin (IL)-33 level and IL-33 gene rs1342326, rs1929992 and rs3939286 polymorphisms in patients with asthma. Methods: Ninety patients aged 18 years and older, who were diagnosed with asthma, and 90 healthy control subjects were included in the study. Serum IL-33 levels were measured by enzyme-linked immunosorbent assay; and IL-33 gene polymorphisms were studied by real-time polymerase chain reaction. Results: IL-33 level was higher in patients with asthma (4.16 [+ or -] 0.88 pg/mL) compared to the control subjects (1.28 [+ or -] 0.37 pg/mL) (p |
doi_str_mv | 10.4274/gulhane.galenos.2020.1438 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2539885915</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A664550502</galeid><sourcerecordid>A664550502</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2668-1efb8e084bacc636d1f3a2847a0cd4b68d58c0a31f09d48e475b71147715cd1c3</originalsourceid><addsrcrecordid>eNptkV1LwzAUhoMoOKf_IeJ1a76bXY4xP2DgjV55EdI0XTPbpCatsn9vxwYiyLk4cHjec-A8ANxilDNSsPvt2Dba23yrW-tDygkiKMeMyjMwI5iJTCJOzsEMU0QyxAp8Ca5S2iEkBMdyBt7XX7od9eCCh6GGycaxg84PNrZ2_HA-oxRqX8Gt9Rb2od13IfaNS12aKNhPQeuHBL_d0MAyBm8ap1uo09B0-hpc1LpN9ubU5-DtYf26eso2L4_Pq-UmM0QImWFbl9IiyUptjKCiwjXVRLJCI1OxUsiKS4M0xTVaVExaVvCywJgVBeamwobOwd1xbx_D52jToHZhjH46qQinCyn5AvNf6vAq5XwdhqhN55JRSyEY54gjMlH5P9RUle2cCd7Wbpr_CSyOARNDStHWqo-u03GvMFIHReqkSJ0UqYMidVBEfwB9mIjx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2539885915</pqid></control><display><type>article</type><title>Evaluation of serum interleukin-33 and gene polymorphisms in patients with bronchial asthma</title><source>Publicly Available Content Database</source><creator>Canoglu, Kadir ; Okutan, Oguzhan ; Tas, Dilaver ; Yilmaz, Ismail ; Yesilbas, Soner ; Caliskan, Tayfun ; Kosar, Ayse Filiz Arpacag ; Kartaloglu, Zafer ; Ayten, Omer ; Uyar, Yasin</creator><creatorcontrib>Canoglu, Kadir ; Okutan, Oguzhan ; Tas, Dilaver ; Yilmaz, Ismail ; Yesilbas, Soner ; Caliskan, Tayfun ; Kosar, Ayse Filiz Arpacag ; Kartaloglu, Zafer ; Ayten, Omer ; Uyar, Yasin</creatorcontrib><description>Aims: Asthma is a chronic inflammatory disease of the airways. The aim of the study was to investigate the association between serum interleukin (IL)-33 level and IL-33 gene rs1342326, rs1929992 and rs3939286 polymorphisms in patients with asthma. Methods: Ninety patients aged 18 years and older, who were diagnosed with asthma, and 90 healthy control subjects were included in the study. Serum IL-33 levels were measured by enzyme-linked immunosorbent assay; and IL-33 gene polymorphisms were studied by real-time polymerase chain reaction. Results: IL-33 level was higher in patients with asthma (4.16 [+ or -] 0.88 pg/mL) compared to the control subjects (1.28 [+ or -] 0.37 pg/mL) (p<0.001). The frequencies of AA, CC and AC alleles for the rs1342326 polymorphism were 52 (57.8%), 5 (5.6%) and 33 (36.7%) in the patient group, and 53 (58.9%), 7 (7.8%) and 30 (33.3%) in the control group, respectively. The frequencies of CC, TT and CT alleles for the rs1929992 polymorphism were 17 (18.9%), 31 (34.4%), and 42 (46.7%) in the patient group and 13 (14.4%), 41 (45.6%), and 36 (40%) in the control group, respectively. The frequencies of CC, TT and CT alleles for the rs3939286 polymorphism were 46 (51.1%), 7 (7.8%), and 37 (41.1%) in the patient group and 44 (48.9%), 9 (10%), and 37 (41.1%) in the control group, respectively. There was no statistically significant difference between the groups in terms of IL-33 gene polymorphisms (rs1342326, rs1929992 and rs3939286) (p=0.784, p=0.304, p=0.863, respectively). Conclusions: The current study showed increased serum IL-33 levels in patients with asthma compared to healthy controls but gene polymorphism studies did not show any significant difference. Keywords: Asthma, IL-33, cytokine</description><identifier>ISSN: 1302-0471</identifier><identifier>EISSN: 2146-8052</identifier><identifier>DOI: 10.4274/gulhane.galenos.2020.1438</identifier><language>eng</language><publisher>Ankara: Galenos Yayinevi Tic. Ltd</publisher><subject>Age ; Asthma ; Care and treatment ; Comparative analysis ; Cytokines ; Disease ; Enzyme-linked immunosorbent assay ; Enzymes ; Ethylenediaminetetraacetic acid ; Genes ; Genetic aspects ; Genetic polymorphisms ; Genotype & phenotype ; Health aspects ; Health care ; Independent sample ; Interleukins ; Pathogenesis ; Patients ; Polymorphism ; Software</subject><ispartof>Gulhane Medical Journal, 2021-06, Vol.63 (2), p.104-109</ispartof><rights>COPYRIGHT 2021 Galenos Yayinevi Tic. Ltd.</rights><rights>2021. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-1579-3392 ; 0000-0003-2785-2492 ; 0000-0001-6767-5246 ; 0000-0002-4660-1595 ; 0000-0002-2275-4378 ; 0000-0002-1288-6115 ; 0000-0003-2163-1795 ; 0000-0001-5707-2716 ; 0000-0002-2954-6168 ; 0000-0002-7905-2430</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2539885915/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2539885915?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,44590,75126</link.rule.ids></links><search><creatorcontrib>Canoglu, Kadir</creatorcontrib><creatorcontrib>Okutan, Oguzhan</creatorcontrib><creatorcontrib>Tas, Dilaver</creatorcontrib><creatorcontrib>Yilmaz, Ismail</creatorcontrib><creatorcontrib>Yesilbas, Soner</creatorcontrib><creatorcontrib>Caliskan, Tayfun</creatorcontrib><creatorcontrib>Kosar, Ayse Filiz Arpacag</creatorcontrib><creatorcontrib>Kartaloglu, Zafer</creatorcontrib><creatorcontrib>Ayten, Omer</creatorcontrib><creatorcontrib>Uyar, Yasin</creatorcontrib><title>Evaluation of serum interleukin-33 and gene polymorphisms in patients with bronchial asthma</title><title>Gulhane Medical Journal</title><description>Aims: Asthma is a chronic inflammatory disease of the airways. The aim of the study was to investigate the association between serum interleukin (IL)-33 level and IL-33 gene rs1342326, rs1929992 and rs3939286 polymorphisms in patients with asthma. Methods: Ninety patients aged 18 years and older, who were diagnosed with asthma, and 90 healthy control subjects were included in the study. Serum IL-33 levels were measured by enzyme-linked immunosorbent assay; and IL-33 gene polymorphisms were studied by real-time polymerase chain reaction. Results: IL-33 level was higher in patients with asthma (4.16 [+ or -] 0.88 pg/mL) compared to the control subjects (1.28 [+ or -] 0.37 pg/mL) (p<0.001). The frequencies of AA, CC and AC alleles for the rs1342326 polymorphism were 52 (57.8%), 5 (5.6%) and 33 (36.7%) in the patient group, and 53 (58.9%), 7 (7.8%) and 30 (33.3%) in the control group, respectively. The frequencies of CC, TT and CT alleles for the rs1929992 polymorphism were 17 (18.9%), 31 (34.4%), and 42 (46.7%) in the patient group and 13 (14.4%), 41 (45.6%), and 36 (40%) in the control group, respectively. The frequencies of CC, TT and CT alleles for the rs3939286 polymorphism were 46 (51.1%), 7 (7.8%), and 37 (41.1%) in the patient group and 44 (48.9%), 9 (10%), and 37 (41.1%) in the control group, respectively. There was no statistically significant difference between the groups in terms of IL-33 gene polymorphisms (rs1342326, rs1929992 and rs3939286) (p=0.784, p=0.304, p=0.863, respectively). Conclusions: The current study showed increased serum IL-33 levels in patients with asthma compared to healthy controls but gene polymorphism studies did not show any significant difference. Keywords: Asthma, IL-33, cytokine</description><subject>Age</subject><subject>Asthma</subject><subject>Care and treatment</subject><subject>Comparative analysis</subject><subject>Cytokines</subject><subject>Disease</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Enzymes</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genetic polymorphisms</subject><subject>Genotype & phenotype</subject><subject>Health aspects</subject><subject>Health care</subject><subject>Independent sample</subject><subject>Interleukins</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Polymorphism</subject><subject>Software</subject><issn>1302-0471</issn><issn>2146-8052</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkV1LwzAUhoMoOKf_IeJ1a76bXY4xP2DgjV55EdI0XTPbpCatsn9vxwYiyLk4cHjec-A8ANxilDNSsPvt2Dba23yrW-tDygkiKMeMyjMwI5iJTCJOzsEMU0QyxAp8Ca5S2iEkBMdyBt7XX7od9eCCh6GGycaxg84PNrZ2_HA-oxRqX8Gt9Rb2od13IfaNS12aKNhPQeuHBL_d0MAyBm8ap1uo09B0-hpc1LpN9ubU5-DtYf26eso2L4_Pq-UmM0QImWFbl9IiyUptjKCiwjXVRLJCI1OxUsiKS4M0xTVaVExaVvCywJgVBeamwobOwd1xbx_D52jToHZhjH46qQinCyn5AvNf6vAq5XwdhqhN55JRSyEY54gjMlH5P9RUle2cCd7Wbpr_CSyOARNDStHWqo-u03GvMFIHReqkSJ0UqYMidVBEfwB9mIjx</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Canoglu, Kadir</creator><creator>Okutan, Oguzhan</creator><creator>Tas, Dilaver</creator><creator>Yilmaz, Ismail</creator><creator>Yesilbas, Soner</creator><creator>Caliskan, Tayfun</creator><creator>Kosar, Ayse Filiz Arpacag</creator><creator>Kartaloglu, Zafer</creator><creator>Ayten, Omer</creator><creator>Uyar, Yasin</creator><general>Galenos Yayinevi Tic. Ltd</general><general>Gulhane Medical Journal</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0003-1579-3392</orcidid><orcidid>https://orcid.org/0000-0003-2785-2492</orcidid><orcidid>https://orcid.org/0000-0001-6767-5246</orcidid><orcidid>https://orcid.org/0000-0002-4660-1595</orcidid><orcidid>https://orcid.org/0000-0002-2275-4378</orcidid><orcidid>https://orcid.org/0000-0002-1288-6115</orcidid><orcidid>https://orcid.org/0000-0003-2163-1795</orcidid><orcidid>https://orcid.org/0000-0001-5707-2716</orcidid><orcidid>https://orcid.org/0000-0002-2954-6168</orcidid><orcidid>https://orcid.org/0000-0002-7905-2430</orcidid></search><sort><creationdate>20210601</creationdate><title>Evaluation of serum interleukin-33 and gene polymorphisms in patients with bronchial asthma</title><author>Canoglu, Kadir ; Okutan, Oguzhan ; Tas, Dilaver ; Yilmaz, Ismail ; Yesilbas, Soner ; Caliskan, Tayfun ; Kosar, Ayse Filiz Arpacag ; Kartaloglu, Zafer ; Ayten, Omer ; Uyar, Yasin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2668-1efb8e084bacc636d1f3a2847a0cd4b68d58c0a31f09d48e475b71147715cd1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Asthma</topic><topic>Care and treatment</topic><topic>Comparative analysis</topic><topic>Cytokines</topic><topic>Disease</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Enzymes</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genetic polymorphisms</topic><topic>Genotype & phenotype</topic><topic>Health aspects</topic><topic>Health care</topic><topic>Independent sample</topic><topic>Interleukins</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Polymorphism</topic><topic>Software</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Canoglu, Kadir</creatorcontrib><creatorcontrib>Okutan, Oguzhan</creatorcontrib><creatorcontrib>Tas, Dilaver</creatorcontrib><creatorcontrib>Yilmaz, Ismail</creatorcontrib><creatorcontrib>Yesilbas, Soner</creatorcontrib><creatorcontrib>Caliskan, Tayfun</creatorcontrib><creatorcontrib>Kosar, Ayse Filiz Arpacag</creatorcontrib><creatorcontrib>Kartaloglu, Zafer</creatorcontrib><creatorcontrib>Ayten, Omer</creatorcontrib><creatorcontrib>Uyar, Yasin</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Gulhane Medical Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Canoglu, Kadir</au><au>Okutan, Oguzhan</au><au>Tas, Dilaver</au><au>Yilmaz, Ismail</au><au>Yesilbas, Soner</au><au>Caliskan, Tayfun</au><au>Kosar, Ayse Filiz Arpacag</au><au>Kartaloglu, Zafer</au><au>Ayten, Omer</au><au>Uyar, Yasin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of serum interleukin-33 and gene polymorphisms in patients with bronchial asthma</atitle><jtitle>Gulhane Medical Journal</jtitle><date>2021-06-01</date><risdate>2021</risdate><volume>63</volume><issue>2</issue><spage>104</spage><epage>109</epage><pages>104-109</pages><issn>1302-0471</issn><eissn>2146-8052</eissn><abstract>Aims: Asthma is a chronic inflammatory disease of the airways. The aim of the study was to investigate the association between serum interleukin (IL)-33 level and IL-33 gene rs1342326, rs1929992 and rs3939286 polymorphisms in patients with asthma. Methods: Ninety patients aged 18 years and older, who were diagnosed with asthma, and 90 healthy control subjects were included in the study. Serum IL-33 levels were measured by enzyme-linked immunosorbent assay; and IL-33 gene polymorphisms were studied by real-time polymerase chain reaction. Results: IL-33 level was higher in patients with asthma (4.16 [+ or -] 0.88 pg/mL) compared to the control subjects (1.28 [+ or -] 0.37 pg/mL) (p<0.001). The frequencies of AA, CC and AC alleles for the rs1342326 polymorphism were 52 (57.8%), 5 (5.6%) and 33 (36.7%) in the patient group, and 53 (58.9%), 7 (7.8%) and 30 (33.3%) in the control group, respectively. The frequencies of CC, TT and CT alleles for the rs1929992 polymorphism were 17 (18.9%), 31 (34.4%), and 42 (46.7%) in the patient group and 13 (14.4%), 41 (45.6%), and 36 (40%) in the control group, respectively. The frequencies of CC, TT and CT alleles for the rs3939286 polymorphism were 46 (51.1%), 7 (7.8%), and 37 (41.1%) in the patient group and 44 (48.9%), 9 (10%), and 37 (41.1%) in the control group, respectively. There was no statistically significant difference between the groups in terms of IL-33 gene polymorphisms (rs1342326, rs1929992 and rs3939286) (p=0.784, p=0.304, p=0.863, respectively). Conclusions: The current study showed increased serum IL-33 levels in patients with asthma compared to healthy controls but gene polymorphism studies did not show any significant difference. Keywords: Asthma, IL-33, cytokine</abstract><cop>Ankara</cop><pub>Galenos Yayinevi Tic. Ltd</pub><doi>10.4274/gulhane.galenos.2020.1438</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-1579-3392</orcidid><orcidid>https://orcid.org/0000-0003-2785-2492</orcidid><orcidid>https://orcid.org/0000-0001-6767-5246</orcidid><orcidid>https://orcid.org/0000-0002-4660-1595</orcidid><orcidid>https://orcid.org/0000-0002-2275-4378</orcidid><orcidid>https://orcid.org/0000-0002-1288-6115</orcidid><orcidid>https://orcid.org/0000-0003-2163-1795</orcidid><orcidid>https://orcid.org/0000-0001-5707-2716</orcidid><orcidid>https://orcid.org/0000-0002-2954-6168</orcidid><orcidid>https://orcid.org/0000-0002-7905-2430</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1302-0471 |
ispartof | Gulhane Medical Journal, 2021-06, Vol.63 (2), p.104-109 |
issn | 1302-0471 2146-8052 |
language | eng |
recordid | cdi_proquest_journals_2539885915 |
source | Publicly Available Content Database |
subjects | Age Asthma Care and treatment Comparative analysis Cytokines Disease Enzyme-linked immunosorbent assay Enzymes Ethylenediaminetetraacetic acid Genes Genetic aspects Genetic polymorphisms Genotype & phenotype Health aspects Health care Independent sample Interleukins Pathogenesis Patients Polymorphism Software |
title | Evaluation of serum interleukin-33 and gene polymorphisms in patients with bronchial asthma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A51%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20serum%20interleukin-33%20and%20gene%20polymorphisms%20in%20patients%20with%20bronchial%20asthma&rft.jtitle=Gulhane%20Medical%20Journal&rft.au=Canoglu,%20Kadir&rft.date=2021-06-01&rft.volume=63&rft.issue=2&rft.spage=104&rft.epage=109&rft.pages=104-109&rft.issn=1302-0471&rft.eissn=2146-8052&rft_id=info:doi/10.4274/gulhane.galenos.2020.1438&rft_dat=%3Cgale_proqu%3EA664550502%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2668-1efb8e084bacc636d1f3a2847a0cd4b68d58c0a31f09d48e475b71147715cd1c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2539885915&rft_id=info:pmid/&rft_galeid=A664550502&rfr_iscdi=true |